152 related articles for article (PubMed ID: 38020179)
1. Targeted IFNγ induction by a genetically engineered
Hua Z; Wu S; Zhang Y; Wang X; Cui J; Li Y; Yang C; Zhai M; Deng B; Yu B; Huang JD; Wang Z; Zhou J
Front Med (Lausanne); 2023; 10():1284120. PubMed ID: 38020179
[TBL] [Abstract][Full Text] [Related]
2. 'Obligate' anaerobic
Li CX; Yu B; Shi L; Geng W; Lin QB; Ling CC; Yang M; Ng KT; Huang JD; Man K
Oncol Lett; 2017 Jan; 13(1):177-183. PubMed ID: 28123538
[TBL] [Abstract][Full Text] [Related]
3. Obligate anaerobic
Yu B; Shi L; Zhang BZ; Zhang KE; Peng X; Niu HB; Qu JL
Oncol Lett; 2015 Aug; 10(2):1069-1074. PubMed ID: 26622627
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Neuroblastoma with an Engineered "Obligate" Anaerobic
Ning BT; Yu B; Chan S; Chan JL; Huang JD; Chan GC
J Cancer; 2017; 8(9):1609-1618. PubMed ID: 28775780
[No Abstract] [Full Text] [Related]
5. Nanophotosensitizer-engineered Salmonella bacteria with hypoxia targeting and photothermal-assisted mutual bioaccumulation for solid tumor therapy.
Chen F; Zang Z; Chen Z; Cui L; Chang Z; Ma A; Yin T; Liang R; Han Y; Wu Z; Zheng M; Liu C; Cai L
Biomaterials; 2019 Sep; 214():119226. PubMed ID: 31174068
[TBL] [Abstract][Full Text] [Related]
6. Genetically modified "obligate" anaerobic Salmonella typhimurium as a therapeutic strategy for neuroblastoma.
Guo ZL; Yu B; Ning BT; Chan S; Lin QB; Li JC; Huang JD; Chan GC
J Hematol Oncol; 2015 Aug; 8():99. PubMed ID: 26286454
[TBL] [Abstract][Full Text] [Related]
7. Tumor-targeting amino acid auxotrophic Salmonella typhimurium.
Hoffman RM
Amino Acids; 2009 Sep; 37(3):509-21. PubMed ID: 19291366
[TBL] [Abstract][Full Text] [Related]
8. Tumor Temporal Proteome Profiling Reveals the Immunological Triple Offensive Induced by Synthetic Anti-Cancer
Yang S; Zhao W; Zhu M; Hu H; Wang W; Zang Z; Jin M; Bi J; Huang J; Liu C; Li X; Yin P; Li N
Front Immunol; 2021; 12():712936. PubMed ID: 34489962
[TBL] [Abstract][Full Text] [Related]
9. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of tumor-targeting Salmonella typhimurium A1-R on human colorectal cancer liver metastasis in orthotopic nude-mouse models.
Murakami T; Hiroshima Y; Zhao M; Zhang Y; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
Oncotarget; 2015 Oct; 6(31):31368-77. PubMed ID: 26375054
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic targeting of tumor-associated macrophages in pancreatic neuroendocrine tumors.
Krug S; Abbassi R; Griesmann H; Sipos B; Wiese D; Rexin P; Blank A; Perren A; Haybaeck J; Hüttelmaier S; Rinke A; Gress TM; Michl P
Int J Cancer; 2018 Oct; 143(7):1806-1816. PubMed ID: 29696624
[TBL] [Abstract][Full Text] [Related]
12. Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice.
Ravichandran G; Neumann K; Berkhout LK; Weidemann S; Langeneckert AE; Schwinge D; Poch T; Huber S; Schiller B; Hess LU; Ziegler AE; Oldhafer KJ; Barikbin R; Schramm C; Altfeld M; Tiegs G
J Hepatol; 2019 Oct; 71(4):773-782. PubMed ID: 31173810
[TBL] [Abstract][Full Text] [Related]
13. YB1 dephosphorylation attenuates atherosclerosis by promoting CCL2 mRNA decay.
Tang Y; Li Z; Yang H; Yang Y; Geng C; Liu B; Zhang T; Liu S; Xue Y; Zhang H; Wang J; Zhao H
Front Cardiovasc Med; 2022; 9():945557. PubMed ID: 35990936
[TBL] [Abstract][Full Text] [Related]
14. Engineered Salmonella inhibits GPX4 expression and induces ferroptosis to suppress glioma growth in vitro and in vivo.
Chen J; Li T; Zhou N; He Y; Zhong J; Ma C; Zeng M; Ji J; Huang JD; Ke Y; Sun H
J Neurooncol; 2023 Jul; 163(3):607-622. PubMed ID: 37351767
[TBL] [Abstract][Full Text] [Related]
15. YB1 regulates miR-205/200b-ZEB1 axis by inhibiting microRNA maturation in hepatocellular carcinoma.
Liu X; Chen D; Chen H; Wang W; Liu Y; Wang Y; Duan C; Ning Z; Guo X; Otkur W; Liu J; Qi H; Liu X; Lin A; Xia T; Liu HX; Piao HL
Cancer Commun (Lond); 2021 Jul; 41(7):576-595. PubMed ID: 34110104
[TBL] [Abstract][Full Text] [Related]
16. Grapefruit-derived nanovectors deliver miR-18a for treatment of liver metastasis of colon cancer by induction of M1 macrophages.
Teng Y; Mu J; Hu X; Samykutty A; Zhuang X; Deng Z; Zhang L; Cao P; Yan J; Miller D; Zhang HG
Oncotarget; 2016 May; 7(18):25683-97. PubMed ID: 27028860
[TBL] [Abstract][Full Text] [Related]
17. Targeting of pancreatic cancer cells and stromal cells using engineered oncolytic Salmonella typhimurium.
Tan W; Duong MT; Zuo C; Qin Y; Zhang Y; Guo Y; Hong Y; Zheng JH; Min JJ
Mol Ther; 2022 Feb; 30(2):662-671. PubMed ID: 34400328
[TBL] [Abstract][Full Text] [Related]
18. Apatinib inhibits tumor growth and angiogenesis in PNET models.
Wu S; Zhou J; Guo J; Hua Z; Li J; Wang Z
Endocr Connect; 2019 Jan; 8(1):8-19. PubMed ID: 30557852
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of YB1 and EZH2 are associated with cancer metastasis and poor prognosis in renal cell carcinomas.
Wang Y; Chen Y; Geng H; Qi C; Liu Y; Yue D
Tumour Biol; 2015 Sep; 36(9):7159-66. PubMed ID: 25877750
[TBL] [Abstract][Full Text] [Related]
20. Tumor-Targeting Salmonella typhimurium A1-R Promotes Tumoricidal CD8
Murakami T; Hiroshima Y; Zhang Y; Zhao M; Kiyuna T; Hwang HK; Miyake K; Homma Y; Mori R; Matsuyama R; Chishima T; Ichikawa Y; Tanaka K; Bouvet M; Endo I; Hoffman RM
J Cell Biochem; 2018 Jan; 119(1):634-639. PubMed ID: 28628234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
